ReviewCancers2023
Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance.
Giovanni Monteleone et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewCancers2023
Giovanni Monteleone et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.